Jason Drew Smith, General Counsel at UroGen Pharma Ltd. (URGN), sold 8,321 shares at $15.78 ($131K) on 2024-02-01, disclosed to the SEC on 2024-02-05.
Open-market sale of $131k URGN by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.78 | 417 | $7K | 5.0% |
| 2 | $15.78 | 1,248 | $20K | 15.0% |
| 3 | $15.78 | 3,328 | $53K | 40.0% |
| 4 | $15.78 | 3,328 | $53K | 40.0% |
| Total | $15.78 avg | 8,321 | $131K | 100% |
| Filing → |
| URGN | SELL | 2025-09-09 | $29K | — | Filing → |
| URGN | SELL | 2025-07-30 | $288K | — | Filing → |
| URGN | SELL | 2025-02-04 | $82K | — | Filing → |